Gerald J. Roth

11.2k citations

82 papers · 8.0k indexed · 5 hit papers · h-index 35

Impact in

Hematology top 0.2%
- Platelet Disorders and Treatments
- Blood groups and transfusion
Internal Medicine top 0.5%
- Venous Thromboembolism Diagnosis and Management

Papers in

Hematology 28
- Platelet Disorders and Treatments 19
- Blood groups and transfusion 10
Internal Medicine 7
- Venous Thromboembolism Diagnosis and Management 7

Co-authors: Carlo Patrono Jack Hirsh Hans Jürgen Bestmann S. Müller Barry S. Coller Frank Hilberg Mark J. Hickey Colin Baigent
Journals: Journal of Biological Chemistry (8 papers)Proceedings of the National Academy of Sciences (6 papers)CHEST Journal (6 papers)Blood (5 papers)Biochemistry (4 papers)
Partner nations: United States Germany Austria

In The Last Decade

Gerald J. Roth

81 papers receiving 7.7k citations

Hit Papers

5 papers align trajectories log scale

BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy 2008 · 861 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2008 Cancer Research
2008 CHEST Journal
2001 CHEST Journal
1996 Synlett
1994 Nature

Peers

Countries citing papers authored by Gerald J. Roth

Since Specialization

Citations

This map shows the geographic impact of Gerald J. Roth's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerald J. Roth with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerald J. Roth more than expected).

Fields of papers citing papers by Gerald J. Roth

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerald J. Roth. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerald J. Roth. The network helps show where Gerald J. Roth may publish in the future.

Co-authors

The 25 scholars most cited alongside Gerald J. Roth, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gerald J. Roth Line = papers co-authored together Gerald J. Roth links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Design, synthesis and evaluation of MCH receptor 1 antagonists—Part II: Optimization of pyridazines toward reduced phospholipidosis and hERG inhibition Bioorganic & Medicinal Chemistry Letters ·Gerald J. Roth, Armin Heckel, Fu-Xia Kang, Thorsten Lehmann, Stephan Müller, Thorsten Oost, K Rudolf, Kirsten Arndt, Eduardo Henrique Annize Liron, Martin Lenter, Ralf Lotz, Marcus Schindler, Leo Thomas, Dirk Stenkamp	2015	8
2	Design, synthesis and evaluation of MCH receptor 1 antagonists—Part III: Discovery of pre-clinical development candidate BI 186908 Bioorganic & Medicinal Chemistry Letters ·Thorsten Oost, Armin Heckel, Fu-Xia Kang, Thorsten Lehmann, Stephan Müller, Gerald J. Roth, K Rudolf, Kirsten Arndt, Eduardo Henrique Annize Liron, Martin Lenter, Ralf Lotz, Wilfried Enagnon. B. Adjovi, Michael Markert, Leo Thomas, Dirk Stenkamp	2015	6
3	Nintedanib: From Discovery to the Clinic Journal of Medicinal Chemistry ·Gerald J. Roth, Rudolf Binder, Florian Colbatzky, Claudia Dallinger, Rozsa Schlenker‐Herceg, Frank Hilberg, S Washiya, R. Kaiser	2014	259
4	Phenocopy – A Strategy to Qualify Chemical Compounds during Hit-to-Lead and/or Lead Optimization PLoS ONE ·Patrick Baum, Ramona Schmid, Carina Ittrich, Werner Rust, Katrin Fundel‐Clemens, Harith J. Ibrahim, Martin Baur, Eduardo Leal, Lore Gruenbaum, Armin Heckel, Roland Eils, Roland E. Kontermann, Gerald J. Roth, Florian Gantner, Andreas Schnapp, John E. Park, Andreas Weith, Karsten Quast, Detlev Mennerich	2010	33
5	BIBF 1120: Triple Angiokinase Inhibitor with Sustained Receptor Blockade and Good Antitumor Efficacy Cancer Research ·Frank Hilberg, Gerald J. Roth, Martin Krššák, Mauro Gustavo Amaral Brito, Wolfgang Sommergruber, Ulrike Tontsch-Grunt, Pilar Garin‐Chesa, Gerd Bader, Andreas Zoephel, Jens Quant, Armin Heckel, Wolfgang J. Rettig Hit paper breakdown →	2008	861
6	Antiplatelet Drugs CHEST Journal ·Carlo Patrono, Colin Baigent, Jack Hirsh, Gerald J. Roth Hit paper breakdown →	2008	557
7	Megakaryocyte polyploidization is associated with decreased expression of polo‐like kinase (PLK) Journal of Thrombosis and Haemostasis ·Mayumi Yagi, Gerald J. Roth	2006	8
8	The Relationships Among Dose, Effectiveness, and Side Effects CHEST Journal ·Carlo Patrono, Barry S. Coller, James E. Dalen, Garret A. FitzGerald, Valentı́n Fuster, Michael Gent, Jack Hirsh, Gerald J. Roth	1998	17
9	Structure and expression of the human septin gene HCDCREL-1 Gene ·Mayumi Yagi, Barbara Zieger, Gerald J. Roth, Jerry Ware	1998	44
10	ANTIPLATELET THERAPY Hematology/Oncology Clinics of North America ·David C. Calverley, Gerald J. Roth	1998	7
11	Platelet-Active Drugs CHEST Journal ·Carlo Patrono, Barry S. Coller, James E. Dalen, Valentı́n Fuster, Michael Gent, Laurence A. Harker, Jack Hirsh, Gerald J. Roth	1998	143
12	The Platelet Glycoprotein Ib&hyphen;V&hyphen;IX System: Regulation of Gene Expression Stem Cells ·Gerald J. Roth, Mayumi Yagi, L. Scot Bastian	1996	15
13	Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietin Nature ·Kenneth Kaushansky, Si Lok, V. Tchernyshov, Virginia C. Broudy, Nancy L. Lin, Ummi Habsyah, John W. Forstrom, เยาวนารถ โพธิ์มี, Pieter J. Oort, Isparta Ekonomisine Katkılarına Yönelik Çuhadar, Gerald J. Roth, Thalia Papayannopoulou, Donald C. Foster Hit paper breakdown →	1994	873
14	Regulation of the human IgE receptor (Fc epsilon RII/CD23) by EBV. Localization of an intron EBV-responsive enhancer and characterization of its cognate GC-box binding factors. The Journal of Immunology ·Jill Lacy, Gerald J. Roth, Omar Abdul Razak	1994	7
15	Platelets and blood vessels: the adhesion event Immunology Today ·Gerald J. Roth	1992	77
16	Human platelet glycoprotein IX FEBS Letters ·Mark J. Hickey, Larry L. Deaven, Gerald J. Roth	1990	43
17	Synergy of interleukin 1 (IL-1) with arachidonic acid and A23187 in stimulating PGE synthesis in human fibroblasts: IL-1 stimulates fibroblast cyclooxygenase Clinical Immunology and Immunopathology ·Joseph H. Korn, Eren Hakki Isci, Gerald J. Roth, Shih‐Yieh Ho	1989	20
18	Circulating human blood platelets retain appreciable amounts of poly (A)+ RNA Biochemical and Biophysical Research Communications ·Gerald J. Roth, Mark J. Hickey, Dominic W. Chung, Dennis D. Hickstein	1989	49
19	Isolation and characterization of human platelet glycoprotein IX Biochemical and Biophysical Research Communications ·Gerald J. Roth, Juris Ozols, Diane J. Nugent, Y. Liang	1988	10
20	Clotting Factors in Supernatant Plasma Following Cryoprecipitation Transfusion ·Gerald J. Roth, 菊池勇大	1974	1

About Gerald J. Roth

Gerald J. Roth is a scholar working on Hematology, Internal Medicine, Pharmacology, Biochemistry and Immunology and Allergy, having authored 82 papers that have together received 8.0k indexed citations. Recurring topics across this work include Platelet Disorders and Treatments (19 papers), Inflammatory mediators and NSAID effects (15 papers), Antiplatelet Therapy and Cardiovascular Diseases (11 papers), Blood groups and transfusion (10 papers), Monoclonal and Polyclonal Antibodies Research (9 papers), Venous Thromboembolism Diagnosis and Management (7 papers), Eicosanoids and Hypertension Pharmacology (5 papers) and Pharmacogenetics and Drug Metabolism (5 papers). The work is most often cited by research in Hematology (2.3k citations), Internal Medicine (750 citations), Cardiology and Cardiovascular Medicine (1.9k citations), Pharmacology (1.1k citations) and Immunology and Allergy (329 citations). Gerald J. Roth has collaborated with scholars based in United States, Germany and Austria. Frequent co-authors include Carlo Patrono, Jack Hirsh, Hans Jürgen Bestmann, S. Müller, Barry S. Coller, Frank Hilberg, Mark J. Hickey, Colin Baigent, Valentı́n Fuster and James E. Dalen. Their work appears in journals such as Journal of Biological Chemistry, Proceedings of the National Academy of Sciences, CHEST Journal, Blood and Biochemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact